Breaking News Instant updates and real-time market news.

APEN

Apollo Endosurgery

$4.20

-1.46 (-25.80%)

05:43
08/11/17
08/11
05:43
08/11/17
05:43

Apollo Endosurgery provides update, clarity to FDA letter to providers

Apollo Endosurgery provided an update and clarifications to a letter the FDA sent to Health Care Providers dated August 10, 2017 relating to potential risks with liquid-filled intragastric balloons, including the company's ORBERA intragastric balloon system. In relation to the ORBERA balloon, the facts are: ORBERA is approved by the FDA as safe and effective in assisting adult patients suffering from obesity with a body mass index of 30 to 40 in losing and maintaining weight. There have been five reported deaths of patients who had received the ORBERA intragastric balloon in four different countries since ORBERA's FDA approval in August of 2015. Apollo self-reported all five cases to the FDA as part of its Global Product Surveillance program. The FDA's letter to Health Care Providers does not indicate that the patient deaths were related to the ORBERA device or the insertion procedures. While the cause of death has not been provided or determined in all cases, Apollo has not received any communication or indication from the attending physicians or hospitals that the deaths have been due to the ORBERA device. Apollo has received no product liability-related claims in connection with these five cases. As stated in the ORBERA Directions For Use, in the period from January 1, 2006 through March 31, 2017, there have been 21 reported deaths of patients while they had an ORBERA, which is an incident rate of less than one one-hundredth of one percent of the more than 277,000 ORBERA balloons distributed in the same time period. Since receiving FDA approval in August 2015, the incident rate remains less than 0.01%. ORBERA remains the only intragastric balloon that meets the American Society of Gastrointestinal Endoscopy's, or ASGE, threshold standards for the treatment of obesity. Todd Newton, CEO of Apollo states: "Patient safety is a key priority in everything we do at Apollo Endosurgery and we take adverse event reporting obligations related to our products very seriously. The FDA letter is an important reminder to the physician community that obesity is a serious disease and many obese patients are affected by one or more co-morbid conditions due to their obesity. In our physician training, we are diligent to emphasize the factors that support the safe and effective use of ORBERA and we will continue to do so."

APEN Apollo Endosurgery
$4.20

-1.46 (-25.80%)

07/24/17
CHLM
07/24/17
INITIATION
Target $11
CHLM
Buy
Apollo Endosurgery initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Matt Hewitt started Apollo Endosurgery initiated with a Buy rating and $11, citing the opportunity he sees in its portfolio of three therapies to treat obesity. One of those three, OverStitch, is a "lottery ticket" that could quadruple the stock if it were to receive reimbursement, Hewitt added.
08/02/17
ROTH
08/02/17
INITIATION
Target $10
ROTH
Buy
Apollo Endosurgery initiated with a Buy at Roth Capital
Roth Capital analyst Chris Lewis started Apollo Endosurgery with a Buy rating and a $10 price target as he believes Apollo is an attractive "masked growth" Med Tech company with long-term growth potential driven by continued strong Endo-Bariatric segment growth, from both Orbera and OverStitch, paired with moderating declines in its Lap-Band Surgical business.

TODAY'S FREE FLY STORIES

CHRW

C.H. Robinson

$78.79

0.36 (0.46%)

13:25
11/22/17
11/22
13:25
11/22/17
13:25
Options
CH Robinson Worldwide call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 09

    Jan

$NSD

NASDAQ Market Internals

13:17
11/22/17
11/22
13:17
11/22/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
11/22/17
11/22
13:16
11/22/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
11/22/17
11/22
13:05
11/22/17
13:05
General news
Canada retail sales preview »

Canada retail sales…

BHGE

Baker Hughes

$30.68

0.02 (0.07%)

13:03
11/22/17
11/22
13:03
11/22/17
13:03
Hot Stocks
Baker Hughes reports U.S. rig count up 8 to 923 rigs »

Baker Hughes reported the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HON

Honeywell

$149.34

-0.014 (-0.01%)

13:00
11/22/17
11/22
13:00
11/22/17
13:00
Options
Defensive option play in Honeywell as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCLR

Oclaro

$6.86

0.37 (5.70%)

12:50
11/22/17
11/22
12:50
11/22/17
12:50
Options
Opening activity in Oclaro calls that expire next week »

Opening activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

DE

Deere

$145.30

6.07 (4.36%)

, HPQ

HP Inc.

$21.02

-1.445 (-6.43%)

12:36
11/22/17
11/22
12:36
11/22/17
12:36
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

DE

Deere

$145.30

6.07 (4.36%)

HPQ

HP Inc.

$21.02

-1.445 (-6.43%)

HPE

HP Enterprise

$13.02

-1.1 (-7.79%)

GME

GameStop

$17.86

1.13 (6.75%)

GES

Guess

$15.80

-2.15 (-11.98%)

GKOS

Glaukos

$23.96

-1.39 (-5.48%)

ROK

Rockwell Automation

$190.25

-2.77 (-1.44%)

EMR

Emerson

$61.78

1.425 (2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 27

    Nov

  • 28

    Nov

  • 11

    Dec

12:35
11/22/17
11/22
12:35
11/22/17
12:35
General news
U.S. VIX equity volatility probed 1-month lows of 9.32 »

U.S. VIX equity…

IRBT

iRobot

$73.07

0.95 (1.32%)

12:26
11/22/17
11/22
12:26
11/22/17
12:26
Hot Stocks
iRobot weakness attributed to steeper Roomba discounts »

Shares of iRobot (IRBT)…Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$35.09

0.28 (0.80%)

12:25
11/22/17
11/22
12:25
11/22/17
12:25
Options
GlaxoSmithKline call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBVX

MabVax Therapeutics

$0.71

0.0541 (8.26%)

12:25
11/22/17
11/22
12:25
11/22/17
12:25
Conference/Events
MabVax Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

$NSD

NASDAQ Market Internals

12:17
11/22/17
11/22
12:17
11/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
11/22/17
11/22
12:16
11/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHN

Achillion

$3.43

-0.02 (-0.58%)

, JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

12:10
11/22/17
11/22
12:10
11/22/17
12:10
Hot Stocks
Johnson & Johnson reports sale of 18.37M shares of Achillion »

In a regulatory filing,…

ACHN

Achillion

$3.43

-0.02 (-0.58%)

JNJ

Johnson & Johnson

$137.11

-1.23 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

XON

Intrexon

$13.69

1.315 (10.63%)

12:05
11/22/17
11/22
12:05
11/22/17
12:05
Options
Intrexon call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

, EBAY

eBay

$35.96

0.43 (1.21%)

12:04
11/22/17
11/22
12:04
11/22/17
12:04
Periodicals
Shoppers to spend 7.3% more online during Thanksgiving weekend, report says »

Shoppers are expected to…

AMZN

Amazon.com

$1,139.49

13.18 (1.17%)

EBAY

eBay

$35.96

0.43 (1.21%)

WMT

Wal-Mart

$96.34

-0.18 (-0.19%)

KSS

Kohl's

$44.83

0.62 (1.40%)

TGT

Target

$57.64

0.3868 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 20

    Feb

  • 18

    Mar

PN

Patriot National

12:04
11/22/17
11/22
12:04
11/22/17
12:04
Hot Stocks
Patriot National slides after reporting forbearance agreement with lenders »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:00
11/22/17
11/22
12:00
11/22/17
12:00
General news
EIA natural gas storage change for week ending November 17 »

Gas inventories 46 Bcf…

12:00
11/22/17
11/22
12:00
11/22/17
12:00
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

PN

Patriot National

11:59
11/22/17
11/22
11:59
11/22/17
11:59
Hot Stocks
Breaking Hot Stocks news story on Patriot National »

Patriot National trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$56.41

-0.33 (-0.58%)

, DISH

Dish

$50.04

0.03 (0.06%)

11:59
11/22/17
11/22
11:59
11/22/17
11:59
Hot Stocks
CBS says still 'far apart' on terms with Dish for new deal »

CBS (CBS) issued the…

CBS

CBS

$56.41

-0.33 (-0.58%)

DISH

Dish

$50.04

0.03 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBOE

CBOE Holdings

$119.63

0.4 (0.34%)

11:55
11/22/17
11/22
11:55
11/22/17
11:55
Options
CBOE Holdings put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
11/22/17
11/22
11:55
11/22/17
11:55
General news
FOMC minutes preview: the minutes won't have much to offer »

FOMC minutes preview: the…

11:45
11/22/17
11/22
11:45
11/22/17
11:45
General news
Breaking General news story  »

Week of 11/17 EIA Natural…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.